Depression of hepatic microsomal enzyme systems by lentinan in mice.
スポンサーリンク
概要
- 論文の詳細を見る
Studies were performed to determine the effects of an immunopotentiating agent, lentinan, on the hepatic drug-metabolizing enzymes in mice. Lentinan was injected twice a day for two days, and the enzyme activities were determined 12 hr after the last injection of lentinan. A lentinan dose of over 0.25 mg/kg was required to cause a significant decrease (20-40%) in the hepatic microsomal aminopyrine <I>N</I>-demethylase and aniline hydroxylase activities. The loss of drug-metabolizing activity by the treatment with lentinan agreed with the loss of cytochrome P-450 content in many cases. Strain and substrate differences concerning the effect of lentinan on the metabolism of drug were also observed. That is to say, the loss of cytochrome P-450 content by the treatment with lentinan was observed in the ddY, C57BL/6 and BDF<SUB>1</SUB> strain mice, but was not observed in the DBA/2, C3H/He and C57BL/10 strain mice. The decrease in the activities of 7-ethoxycoumarin <I>O</I>-deethylase and biphenyl 2-hydroxylase by the treatment with lentinan was considerably less than that of aminopyrine <I>N</I>-demethylase and aniline hydroxylase in ddY mice.
- 公益社団法人 日本薬理学会の論文
著者
-
Sasaki Ken-ichi
Cancer Resarch Institute Tohoku College Of Pharmaceutical Sciences
-
Takayanagi Giichi
Cancer Resarch Institute Tohoku College Of Pharmaceutical Sciences
-
ISHIKAWA Masaaki
Cancer Research Institute, Tohoku College of Pharmaceutical Sciences
-
SASAKI Minoru
Cancer Research Institute, Tohoku College of Pharmaceutical Sciences
関連論文
- Role of Endogenous Endotoxin on Tumor Necrosis Factor-Hypersensitivity Caused by D-Galactosamine Challenge
- Effects of Antitumor Activity and Protection of Shock Symptoms by a Traditional Chinese Medicine (Sho-Saiko-To) in Recombinant Human Tumor Necrosis Factor Administered Mice
- Reduction of Cyclophosphamide-Induced Toxicity by Diethyldithiocarbamate and Carbon Disulfide and Its Possible Mechanism
- BIPHASIC EFFECT OF DOXAPRAM ON HYPNOTIC ACTIVITY OF PENTOBARBITAL IN MICE
- EFFECTS OF CHLORDIAZEPOXIDE, DIAZEPAM AND OXAZEPAM ON THE ANTITUMOR ACTIVITY, THE LETHALITY AND THE BLOOD LEVEL OF ACTIVE METABOLITES OF CYCLOPHOSPHAMIDE AND CYCLOPHOSPHAMIDE OXIDASE ACTIVITY IN MICE
- EFFECT OF DOXAPRAM ON THE ACTION OF OTHER DRUGS AND THE HEPATIC DRUG-METABOLIZING SYSTEM IN MICE
- DRUG INTERACTION OF ANTITUMOR DRUGS III. ANTITUMOR ACTIVITY OF TEGAFUR IN LIPOPOLYSACCHARIDE-TREATED MICE
- EFFECT OF TINORIDINE ON DOXORUBICIN-INDUCED LETHALITY IN MICE
- Effect of lipopolysaccharide (from Escherichia coli) on the hepatic drug-metabolizing activities in successively LPS-treated mice.
- Reversal of resistance to doxorubicin with cepharanthine in murine P388 leukemia cells.
- Effect of buthionine sulfoximine, an inhibitor of glutathione biosynthesis, on the selenium-induced lethality in mice.
- Depression of hepatic microsomal enzyme systems by lentinan in mice.